Editorial
Split Viewer
Blood Res 2013; 48(1):
Published online March 31, 2013
https://doi.org/10.5045/br.2013.48.1.1
© The Korean Society of Hematology
Blood Research: hematology and beyond
Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
REFERENCES
- Stroncek, DF, Berger, C, Cheever, MA, et al. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med, 2012;10;48.
- Rosenberg, SA, Yang, JC, Sherry, RM, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res, 2011;17;4550-4557.
- Park, TS, Rosenberg, SA, Morgan, RA. Treating cancer with genetically engineered T cells. Trends Biotechnol, 2011;29;550-557.
- Restifo, NP, Dudley, ME, Rosenberg, SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol, 2012;12;269-281.
- Sabatino, M, Ren, J, David-Ocampo, V, et al. The establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med, 2012;10;23.
PDF
Standard view
Export citation
Share Article
Editorial
Blood Res 2013; 48(1): 1-2
Published online March 31, 2013 https://doi.org/10.5045/br.2013.48.1.1
Copyright © The Korean Society of Hematology.
Blood Research: hematology and beyond
David F. Stroncek, M.D.
Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
- Stroncek, DF, Berger, C, Cheever, MA, et al. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med, 2012;10;48.
- Rosenberg, SA, Yang, JC, Sherry, RM, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res, 2011;17;4550-4557.
- Park, TS, Rosenberg, SA, Morgan, RA. Treating cancer with genetically engineered T cells. Trends Biotechnol, 2011;29;550-557.
- Restifo, NP, Dudley, ME, Rosenberg, SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol, 2012;12;269-281.
- Sabatino, M, Ren, J, David-Ocampo, V, et al. The establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med, 2012;10;23.
Previous Article
